Detection of Oral and Throat Cancers Using OralViome Cancer Testing System

RecruitingOBSERVATIONAL
Enrollment

475

Participants

Timeline

Start Date

May 27, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Oral Squamous Cell CarcinomaOropharynx Squamous Cell CarcinomaPremalignant Lesion
Interventions
DEVICE

OralViome Cancer Testing System

The OralViome Cancer Testing System is intended for the screening of Oral Squamous Cell Carcinoma (OSCC) and Oropharyngeal cancer (OPC). The system consists of the OralViome Saliva Collection and Transport Kit, the Viome laboratory process for metatranscriptomics, and the Viome analytical software that detects an RNA expression signature within a saliva sample.

Trial Locations (1)

10595

RECRUITING

NYMC, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

New York Medical College

OTHER

lead

Viome

INDUSTRY